AA & MDSIF Bone Marrow Failure Disease Symposium

Wauwatosa, WI US
November 4, 2016

Since bone marrow failure diseases are rare, clinicians may not be aware of the presenting signs and symptoms and thus delay earlier diagnosis and treatment.

Practitioners who see very few bone marrow failure disease patients may not be up-to-date on the clinical implications of cytogenetic and molecular abnormalities on diagnosis and treatment.

Clinicians may be relying only on bone marrow biopsies and not the latest technology to determine the pathogenesis and therapeutic options for bone marrow failure diseases.

Practitioners may not see many bone marrow failure disease patients and thus are not up-to-date on recent advances in treatment options;

Transplantation for bone marrow failure diseases may not be considered for patients over a certain age or without a related matched donor.

ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and AA MDS International Foundation. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 3.5 hours of participation for continuing education for allied health professionals. 

AGENDA

12:20 noon –      1:00 pm

Registration and Lunch
1:00 pm  –      
  1:10 pm
Welcome by Course Director
Ehab Atallah, MD
1:10 pm  –      
  2:00 pm

Aplastic Anemia & PNH
Jaroslaw Maciejewski, MD, PhD
Cleveland Clinic

2:00 pm  –      
  2:45 pm

Myelodysplastic Syndromes (MDS)
Ryan Mattison, MD
University of Wisconsin - Madison

2:45 pm  –      
  3:00 pm
Break
3:00 pm  –      
  3:40 pm

Myeloproliferative Neoplasms (MPN)
Laura Michaelis, MD
Medical College of Wisconsin

3:40 pm  –      
  4:10 pm

Hematopoietic Stem Cell Transplantation
Parameswaran Hari, MD, MS 
Medical College of Wisconsin

4:10 pm  –      
  4:40 pm

Diagnostic Challenges: The Pathologists Perspective
Paul Hosking MD
Medical College of Wisconsin

4:40 pm  –      
  5
:00 pm
Panel Discussion

 

Jointly provided by The Medical College of Wisconsin and the AA MDS International Foundation

Target Audience

Physicians and Allied Health Care Professionals

Learning Objectives

  1. Provide accurate differential diagnosis of bone marrow failure diseases, including MDS, aplastic anemia, PNH and MPN;
  2. Critically appraise recent advances in research on the genetic characteristics of bone marrow failure diseases;
  3. Summarize recent progress in understanding the pathogenesis of myeloid malignancies and bone marrow failure diseases
  4. Describe safety and efficacy data for currently available therapies for bone marrow failure diseases;
  5. Identify current therapeutic standards, as well as new and emerging therapies used in HCT.
Additional information

Contact

Name: 
Dan Bullock
Phone Number: 
+1 (414) 805-4617
Course summary
Available credit: 
  • 3.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.50 Hours of Participation
    Hours of Participation credit.
Course opens: 
08/27/2016
Course expires: 
02/10/2017
Event starts: 
11/04/2016 - 12:00pm CDT
Event ends: 
11/04/2016 - 5:00pm CDT
Cost:
$0.00
Crowne Plaza Milwaukee West
10499 Innovation Drive
Phone: (414) 475-9500
Wauwatosa, WI 53226
United States

Crowne Plaza Milwaukee West
10499 Innovation Drive
Wauwatosa, WI 53226

 


Registration Information



Registration is required for this complementary course.

Jaroslaw Maciejewski, MD, PhD
Chairman of Translational Hematology and Oncology Research
Cleveland Clinic Cancer Institute

Ryan Mattison
Assistant Professor of Hematology & Oncology
University of Wisconsin School of Medicine and Public Health

Laura Michaelis, MD
Associate Professor of Medicine
Medical College of Wisconsin

Parameswaran Hari, MD, MS
Armand Quick Professor of Hematology
Director of Adult Blood and Marrow Transplant Program
Section Head of Hematologic Malignancies and BMT
Professor of Medicine
Medical College of Wisconsin

Paul Hosking, MD
Medical College of Wisconsin

Ehab Atallah, MD
Associate Professor of Medicine
Medical College of Wisconsin


All persons in control of content have NO relevant relationships to disclose with the exception of:

 

Parameswaran Hari, MD, MS, Celgene, Takeda

Ryan Mattison, MD, CTI Biopharma

Jaroslaw Maciejewski, MD, Celgene, Alexion

Laura Michaelis, MD, Incyte, Pfizer, Celgene

 

In accordance with the ACCME® standards for Commercial Support # 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of resolution process and resolved.

 

 

Available Credit

  • 3.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.50 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$0.00
Please login or register to take this course.